IDEAS home Printed from https://ideas.repec.org/f/pma2581.html
   My authors  Follow this author

Andrea Marcellusi

Personal Details

First Name:Andrea
Middle Name:
Last Name:Marcellusi
Suffix:
RePEc Short-ID:pma2581

Affiliation

(80%) Faculty of Business
Kingston University

Kingston-upon-Thames, United Kingdom
http://business.kingston.ac.uk/

+44 (0)20 8547 2000

Kingston Hill, Kingston Upon Thames, Surrey, KT2 7LB
RePEc:edi:fbkinuk (more details at EDIRC)

(20%) Centro di Studi Internazionali Sull'Economia e la Sviluppo (CEIS)
Facoltà di Economia
Università degli Studi di Roma "Tor Vergata"

Roma, Italy
http://www.ceistorvergata.it/

0039 06 2040234
0039 06 2020687
Via Columbia, 2 00133 Roma
RePEc:edi:csrotit (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Andrea Marcellusi & Raffaella Viti & Francesco Damele & Calogero Cammà & Gloria Taliani & Francesco Saverio Mennini, 2016. "Early treatment in HCV: is it a cost-effective option from the Italian perspective?," CEIS Research Paper 370, Tor Vergata University, CEIS, revised 23 Mar 2016.
  2. F.S. Mennini & A. Marcellusi & J.M. Graf von der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," Post-Print hal-01616348, HAL.
  3. Francesco Saverio Mennini & Paolo Sciattella & Andrea Marcellusi & Alberico Marcobelli & Alessandra Russo & Achille Patrizio Caputi, 2015. "Treatment Plan Comparison in Obstructive Respiratory Disorders: an Observational Study of Doxofylline vs. Theophylline in the Marche Region," CEIS Research Paper 356, Tor Vergata University, CEIS, revised 13 Oct 2015.
  4. Andrea Marcellusi & Raffaella Viti & Alessandra Mecozzi & Francesco Saverio Mennini, 2014. "Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach," CEIS Research Paper 321, Tor Vergata University, CEIS, revised 05 Aug 2014.
  5. Francesco Saverio Mennini & Andrea Marcellusi & Massimo Andreoni & Antonio Gasbarrini & Salvatore Salomone & Antonio Craxì, 2014. "Health Policy Model: Long-term Predictive Results Associated With The Management Of HCV-Induced Diseases In Italy," CEIS Research Paper 308, Tor Vergata University, CEIS, revised 17 Feb 2014.
  6. Francesco Saverio Mennini & Simone Russo & Andrea Marcellusi & Giuseppe Quintaliani & Denis Fouque, 2013. "Economic effects of treatment of chronic kidney disease with low-protein diet," CEIS Research Paper 292, Tor Vergata University, CEIS, revised 10 Oct 2013.
  7. Francesco Saverio Mennini & Andrea Marcellusi & J.Matthias Graf von der Schulenburg & Alastair Gray & Pierre L. Levy & Paolo Sciattella & Marco Soro & Gianandrea Staffiero & Jan Zeidler & Aldo Maggion, 2013. "Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe," CEIS Research Paper 299, Tor Vergata University, CEIS, revised 13 Dec 2013.

Articles

  1. Andrea Marcellusi & Raffaella Viti & Loreta A. Kondili & Stefano Rosato & Stefano Vella & Francesco Saverio Mennini, 2019. "Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data," PharmacoEconomics, Springer, vol. 37(2), pages 255-266, February.
  2. Paolo Massimo Buscema & Lara Gitto & Simone Russo & Andrea Marcellusi & Federico Fiori & Guido Maurelli & Giulia Massini & Francesco Saverio Mennini, 2017. "The perception of corruption in health: AutoCM methods for an international comparison," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(1), pages 459-477, January.
  3. A. Marcellusi & R. Viti & A. Mecozzi & F. Mennini, 2016. "The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(2), pages 139-147, March.
  4. F. Mennini & Andrea Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder, 2015. "Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 909-911, November.
  5. F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 65-72, January.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Andrea Marcellusi & Raffaella Viti & Francesco Damele & Calogero Cammà & Gloria Taliani & Francesco Saverio Mennini, 2016. "Early treatment in HCV: is it a cost-effective option from the Italian perspective?," CEIS Research Paper 370, Tor Vergata University, CEIS, revised 23 Mar 2016.

    Cited by:

    1. Andrea Marcellusi & Raffaella Viti & Loreta A. Kondili & Stefano Rosato & Stefano Vella & Francesco Saverio Mennini, 2019. "Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data," PharmacoEconomics, Springer, vol. 37(2), pages 255-266, February.
    2. Nicola Squillace & Elena Ricci & Tiziana Quirino & Andrea Gori & Alessandra Bandera & Laura Carenzi & Giuseppe Vittorio De Socio & Giancarlo Orofino & Canio Martinelli & Giordano Madeddu & Stefano Rus, 2017. "Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOL," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-11, June.

  2. F.S. Mennini & A. Marcellusi & J.M. Graf von der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," Post-Print hal-01616348, HAL.

    Cited by:

    1. Maria Teresa Greco & Antonio Giampiero Russo, 2017. "Valutazione del modello CREG utilizzato dalla ATS della Città Metropolitana di Milano per la gestione delle malattie croniche nella medicina generale," MECOSAN. Menagement e economia sanitaria, FrancoAngeli Editore, vol. 2017(101), pages 31-50.
    2. Klaus Mann & Michael Möcker & Joachim Grosser, 2019. "Adherence to long-term prophylactic treatment: microeconomic analysis of patients’ behavior and the impact of financial incentives," Health Economics Review, Springer, vol. 9(1), pages 1-10, December.

  3. Andrea Marcellusi & Raffaella Viti & Alessandra Mecozzi & Francesco Saverio Mennini, 2014. "Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach," CEIS Research Paper 321, Tor Vergata University, CEIS, revised 05 Aug 2014.

    Cited by:

    1. Paola Rucci & Vera Maria Avaldi & Claudio Travaglini & Cristina Ugolini & Elena Berti & Maria Luisa Moro & Maria Pia Fantini, 2020. "Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis," PharmacoEconomics - Open, Springer, vol. 4(1), pages 181-190, March.
    2. François-Olivier Baudot & Anne-Sophie Aguadé & Thomas Barnay & Christelle Gastaldi-Ménager & Anne Fagot-Campagna, 2018. "Impact of type 2 diabetes on health expenditure: an estimation based on individual administrative data," TEPP Working Paper 2018-04, TEPP.
    3. J. Pöhlmann & K. Norrbacka & K. S. Boye & W. J. Valentine & H. Sapin, 2020. "Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1179-1196, November.

  4. Francesco Saverio Mennini & Andrea Marcellusi & Massimo Andreoni & Antonio Gasbarrini & Salvatore Salomone & Antonio Craxì, 2014. "Health Policy Model: Long-term Predictive Results Associated With The Management Of HCV-Induced Diseases In Italy," CEIS Research Paper 308, Tor Vergata University, CEIS, revised 17 Feb 2014.

    Cited by:

    1. Andrea Marcellusi & Raffaella Viti & Francesco Damele & Calogero Cammà & Gloria Taliani & Francesco Saverio Mennini, 2016. "Early treatment in HCV: is it a cost-effective option from the Italian perspective?," CEIS Research Paper 370, Tor Vergata University, CEIS, revised 23 Mar 2016.
    2. Elisabetta Garagiola & Emanuela Foglia & Lucrezia Ferrario & Paola Meraviglia & Alessandro Tebini & Barbara Menzaghi & Chiara Atzori & Giuliano Rizzardini & Teresa Bini & Antonella D’Arminio Monforte , 2020. "Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice," Health Economics Review, Springer, vol. 10(1), pages 1-11, December.
    3. Umberto Restelli & Alfredo Alberti & Adriano Lazzarin & Marzia Bonfanti & Carmela Nappi & Davide Croce, 2018. "Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affecte," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 37-44, January.

  5. Francesco Saverio Mennini & Simone Russo & Andrea Marcellusi & Giuseppe Quintaliani & Denis Fouque, 2013. "Economic effects of treatment of chronic kidney disease with low-protein diet," CEIS Research Paper 292, Tor Vergata University, CEIS, revised 10 Oct 2013.

    Cited by:

    1. Giuseppe Turchetti & S. Bellelli & M. Amato & S. Bianchi & P. Conti & A. Cupisti & V. Panichi & A. Rosati & F. Pizzarelli, 2017. "The social cost of chronic kidney disease in Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(7), pages 847-858, September.

Articles

  1. Paolo Massimo Buscema & Lara Gitto & Simone Russo & Andrea Marcellusi & Federico Fiori & Guido Maurelli & Giulia Massini & Francesco Saverio Mennini, 2017. "The perception of corruption in health: AutoCM methods for an international comparison," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(1), pages 459-477, January.

    Cited by:

    1. Nida Shahid & Tim Rappon & Whitney Berta, 2019. "Applications of artificial neural networks in health care organizational decision-making: A scoping review," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-22, February.
    2. Bo Sui & Gen-Fu Feng & Chun-Ping Chang, 2018. "The pioneer evidence of contagious corruption," Quality & Quantity: International Journal of Methodology, Springer, vol. 52(2), pages 945-968, March.

  2. A. Marcellusi & R. Viti & A. Mecozzi & F. Mennini, 2016. "The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(2), pages 139-147, March.
    See citations under working paper version above.
  3. F. Mennini & Andrea Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder, 2015. "Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 909-911, November.

    Cited by:

    1. Maria Teresa Greco & Antonio Giampiero Russo, 2017. "Valutazione del modello CREG utilizzato dalla ATS della Città Metropolitana di Milano per la gestione delle malattie croniche nella medicina generale," MECOSAN. Menagement e economia sanitaria, FrancoAngeli Editore, vol. 2017(101), pages 31-50.

  4. F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 65-72, January.
    See citations under working paper version above.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Featured entries

This author is featured on the following reading lists, publication compilations, Wikipedia, or ReplicationWiki entries:
  1. Associazione Italiana di Economia Sanitaria - AIES

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 4 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (4) 2013-10-18 2014-03-01 2014-08-25 2016-04-04. Author is listed
  2. NEP-UPT: Utility Models & Prospect Theory (1) 2016-04-04. Author is listed

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Andrea Marcellusi should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.